SIGA Technologies(us:SIGA)
5.92
+0.17%
Updated on 2024-12-23
Open:5.92
Close:5.92
High:6.01
Low:5.74
Pre Close:5.91
Volume:224695.00
Amount:1.33M
Turnover:0.31%
Shares:71.40M
MarketCap:422.72M
About SIGA Technologies Company
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The firm develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.
Company Name: SIGA Technologies
Company Address: 31 East 62nd Street
Employees: 45
Fiscar Year: 12-31
IPO Date: 1997-09-09
Website: http://www.siga.com
CIK: 1010086
View all SEC Filings
About
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The firm develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.
Address:31 East 62nd Street
Website:http://www.siga.com
Market Movers